Treatments with Ang II receptor blockers and/or ACE inhibitors have been shown to improve kidney injury although the kidney function remained unchanged37, suggesting that the benefit of RAAS blockade in CsA nephropathy is more relevant to long term reduction in renal fibrosis and less relevant to short-term improvement in renal function. The gene discussed is ACE; the disease is renal fibrosis.